The University of Notre Dame and Catalyst Pharmaceuticals Host Inaugural Catalyst Advocacy Scholars Summit (CASS)

Core Insights - Catalyst Pharmaceuticals, Inc. is launching the inaugural Catalyst Advocacy Scholars Summit in collaboration with The University of Notre Dame to enhance student engagement in the biopharmaceutical industry [1][2] - The program aims to provide students with an immersive experience in patient advocacy and the challenges of delivering medicine for rare diseases [1][2] - Catalyst Pharmaceuticals is recognized for its commitment to improving the lives of patients with rare diseases and has been acknowledged on Forbes and Deloitte lists for its success and growth [3] Group 1 - The Catalyst Advocacy Scholars Summit will take place from January 5 to 9, 2026, in Coral Gables, Florida, and will involve 12 selected students [2] - The program is designed to attract talented individuals to the biopharmaceutical sector and enhance patient focus within scientific education [2] - Catalyst Pharmaceuticals emphasizes its dedication to patient care and accessibility, providing comprehensive support services to ensure patients receive necessary treatments [3] Group 2 - Catalyst Pharmaceuticals has a strong U.S. presence, which is central to its commercial strategy, while also exploring opportunities for global expansion [3] - The company has a proven track record of bringing innovative therapies to market, focusing on in-licensing and commercialization [3] - Catalyst was recognized as one of America's Most Successful Mid-Cap Companies and one of North America's Fastest-Growing Companies in 2025 [3]